Twana Alkasalias

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024;25(14):7590
Transcriptomic Profile of Breast Tissue of Premenopausal Women Following Treatment with Progesterone Receptor Modulator: Secondary Outcomes of a Randomized Controlled Trial
Utjes D; Boggavarapu NR; Rasul MF; Koberg I; Zulliger A; Ponandai-Srinivasan S; von Grothusen C; Lalitkumar PG; Papaikonomou K; Alkasalias T; Gemzell-Danielsson K
Article: CANCERS. 2024;16(6):1186
Natural Killer Cell Dysfunction in Premenopausal BRCA1 Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis
Haran S; Chindera K; Sabry M; Wilkinson N; Arora R; Zubiak A; Bartlett TE; Evans I; Jones A; Reisel D; Herzog C; Alkasalias T; Newman M; Kim J; Radestad AF; Gemzell-Danielsson K; Rosenthal AN; Dubeau L; Lowdell MW; Widschwendter M
Article: HELIYON. 2024;10(1):e23831
Retinoblastoma vulnerability to combined de novo and salvage pyrimidine ribonucleotide synthesis pharmacologic blockage
Mollick T; Darekar S; Dalarun B; Plastino F; Zhang J; Fernandez AP; Alkasalias T; Andre H; Lain S
Article: CELL DEATH DISCOVERY. 2022;8(1):464
Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells
Alkasalias T; Zhang J; Madapura H; Dalarun B; Reina OB; Lewensohn R; Viktorsson K; Salihi A; Darekar S; Lain S
Article: EMBO MOLECULAR MEDICINE. 2020;12(4):e11177
Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
Moyano-Galceran L; Pietila EA; Turunen SP; Corvigno S; Hjerpe E; Bulanova D; Joneborg U; Alkasalias T; Miki Y; Yashiro M; Chernenko A; Jukonen J; Singh M; Dahlstrand H; Carlson JW; Lehti K
Journal article: CLINICAL CANCER RESEARCH. 2019;25(22_Supplement):gmm-041-gmm-041
Abstract GMM-041: OVARIAN CANCER CELLS INDUCE A FEEDBACK RESPONSE TO PLATINUM-BASED CHEMOTHERAPY BY ACTIVATING AN ONCOGENIC RSK-EPHA2-GPRC5A SIGNALING SWITCH
Moyano-Galceran L; Turunen SP; Pietilä E; Alkasalias T; Corvigno S; Hjerpe E; Joneborg U; Bulanova D; Eriksson M; Dahlstrand H; Carlson J; Lehti K
Article: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2018;22(1):163-172
Prokineticin 1 is up-regulated by insulin in decidualizing human endometrial stromal cells
Ujvari D; Jakson I; Oldmark C; Attarha S; Alkasalias T; Salamon D; Gidlof S; Hirschberg AL
Article: CLINICAL CANCER RESEARCH. 2017;23(16):4769-4779
A Zebrafish Model Discovers a Novel Mechanism of Stromal Fibroblast-Mediated Cancer Metastasis
Liu C; Zhang Y; Lim S; Hosaka K; Yang Y; Pavlova T; Alkasalias T; Hartman J; Jensen L; Xing X; Wang X; Lu Y; Nie G; Cao Y
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2017;114(8):E1413-E1421
RhoA knockout fibroblasts lose tumor-inhibitory capacity in vitro and promote tumor growth in vivo
Alkasalias T; Alexeyenko A; Hennig K; Danielsson F; Lebbink RJ; Fielden M; Turunen SP; Lehti K; Kashuba V; Madapura HS; Bozoky B; Lundberg E; Balland M; Guven H; Klein G; Gad AKB; Pavlova T
Article: JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH. 2015;34(1):62
Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth
Alexeyenko A; Alkasalias T; Pavlova T; Szekely L; Kashuba V; Rundqvist H; Wiklund P; Egevad L; Csermely P; Korcsmaros T; Guven H; Klein G
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2014;111(48):17188-17193
Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent
Alkasalias T; Flaberg E; Kashuba V; Alexeyenko A; Pavlova T; Savchenko A; Szekely L; Klein G; Guven H

Alla övriga publikationer

Preprint: MEDRXIV. 2024
Transcriptomic profile of normal breast tissue post-mifepristone treatment: secondary outcomes of a randomized controlled trial
Utjés D; Boggavarapu NR; Rasul M; Koberg I; Zulliger A; Ponandai-Srinivasan S; von Grothusen C; Lalitkumar PG; Papaikonomou K; Alkasalias T; Gemzell-Danielsson K
Corrigendum: CELL DEATH DISCOVERY. 2022;8(1):472
Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells (vol 15, pg 548, 2022)
Alkasalias T; Zhang J; Madapura H; Dalarun B; Reina OB; Lewensohn R; Viktorsson K; Salihi A; Darekar S; Lain S
Preprint: RESEARCH SQUARE. 2022
Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells
Lain S; Alkasalias T; Zhang J; Madapura H; Dalaroun B; Reina OB; Lewensohn R; Viktorsson K; Salihi A; Darekar S
Review: MOLECULAR MEDICINE REPORTS. 2022;26(1):233
Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy
Salihi A; Al-Naqshabandi MA; Khudhur ZO; Housein Z; Hama HA; Abdullah RM; Hussen BM; Alkasalias T
Review: FOOD AND CHEMICAL TOXICOLOGY. 2021;150:112087
Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review
Smail SW; Saeed M; Alkasalias T; Khudhur ZO; Younus DA; Rajab MF; Abdulahad WH; Hussain HI; Niaz K; Safdar M
Conference publication: CLINICAL CANCER RESEARCH. 2019;25(22):104
OVARIAN CANCER CELLS INDUCE A FEEDBACK RESPONSE TO PLATINUM-BASED CHEMOTHERAPY BY ACTIVATING AN ONCOGENIC RSK-EPHA2-GPRC5A SIGNALING SWITCH
Moyano-Galceran L; Turunen SP; Pietila E; Alkasalias T; Corvigno S; Hjerpe E; Joneborg U; Bulanova D; Eriksson M; Dahlstrand H; Carlson J; Lehti K
Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2018;19(5):E1532-1532
Fibroblasts in the Tumor Microenvironment: Shield or Spear?
Alkasalias T; Moyano-Galceran L; Arsenian-Henriksson M; Lehti K
Thesis / dissertation: 2017
Tumor microenvironment : the paradoxical action of fibroblasts
Alkasalias, Twana

Anställningar

Biträdande Lektor, Kvinnors och barns hälsa, Karolinska Institutet, 2023-2028

Examina och utbildning

Medicine Doktorsexamen, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 2018

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI